More Press Releases

View Older Stories View Newer Stories

Mar 17, 2026 04:35PM Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026

Mar 17, 2026 04:35PM Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)

Mar 17, 2026 04:35PM Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 17, 2026 10:05AM Dollar Surge Weighs on Gold’s Rally

Mar 17, 2026 04:35PM Synthekine Announces AACR 2026 Oral Presentation of Updated Phase 1a/1b Clinical and Translational Data for STK‑012 in First‑Line Nonsquamous NSCLC with Features of Immunotherapy Resistance

Mar 17, 2026 04:35PM Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival

Mar 17, 2026 04:35PM Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

Mar 17, 2026 04:32PM UnitedHealth Group Announces Earnings Release Date

Mar 17, 2026 04:31PM Sportradar to Participate in the 38th Annual Roth Conference

Mar 17, 2026 04:31PM Elbit Systems Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2025

Mar 17, 2026 04:31PM Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

Mar 17, 2026 04:31PM Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

Mar 17, 2026 04:31PM Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting

Mar 17, 2026 04:30PM Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting

Mar 17, 2026 04:30PM Oklo’s Atomic Alchemy Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of its Groves Isotopes Test Reactor

Mar 17, 2026 04:30PM Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026

Mar 17, 2026 04:30PM SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting

Mar 17, 2026 04:30PM Beazer Homes Announces Expansion of Revolving Credit Facility to $525 million

Mar 17, 2026 04:30PM SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference

Mar 17, 2026 04:30PM Fulton Financial Corporation Declares Common and Preferred Dividends

Mar 17, 2026 04:30PM Pheast Therapeutics to Present Initial Phase 1a Clinical Data and Two New Preclinical Studies of PHST001, a Novel Anti-CD24 Antibody, at AACR 2026

Mar 17, 2026 04:30PM Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026

Mar 17, 2026 04:30PM NVIDIA Nemotron Powers Ceramic Supervised Generation to Ground AI Responses at Enterprise Scale

Mar 17, 2026 04:30PM Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026

Mar 17, 2026 04:30PM Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier™ Platform at AACR Annual Meeting 2026

Mar 17, 2026 04:30PM Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Mar 17, 2026 04:30PM Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026

Mar 17, 2026 04:30PM Pyxus Empowers Growers with New Mobile App

Mar 17, 2026 04:30PM Cboe Global Markets Announces Date of First-Quarter 2026 Earnings Release and Conference Call

Mar 17, 2026 04:30PM Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026

Mar 17, 2026 04:25PM 420 with CNW — IRS Clarifies Post-Rescheduling 280E MSO Marijuana Tax Arrears

Mar 17, 2026 04:30PM Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days

Mar 17, 2026 04:30PM TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares

Mar 17, 2026 04:30PM BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026

Mar 17, 2026 04:30PM Molecular Partners to Hold Three Poster Presentations at AACR 2026

Mar 17, 2026 04:30PM ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 17, 2026 04:30PM Akari Therapeutics Announces ADS Ratio Change

Mar 17, 2026 04:30PM Parsons Announces New Chief Human Resources Officer

Mar 17, 2026 04:30PM UMH PROPERTIES, INC. PUBLISHES ITS 2025 ANNUAL REPORT

Mar 17, 2026 04:30PM Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

Mar 17, 2026 04:30PM Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

Mar 17, 2026 04:30PM Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy

Mar 17, 2026 04:30PM Rainy Mountain Announces Appointment of Colton Griffith to Board of Directors

Mar 17, 2026 04:30PM Evaxion to present new data at AACR Annual Meeting

Mar 17, 2026 04:30PM Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

Mar 17, 2026 04:25PM Sixth Street Specialty Lending, Inc. Provides a Letter to Stakeholders

Mar 17, 2026 04:24PM NNIT A/S: New CEO to lead NNIT into its next phase of growth

Mar 17, 2026 04:23PM JLL secures $370M refinancing for Society Brooklyn in Gowanus

Mar 17, 2026 04:19PM Federal Court Dismisses Lawsuit Against Full Sail University and Other Defendants

Mar 17, 2026 10:05AM Why Honda is Abandoning Plans to Make 3 EVs in the US

View Newer Stories View Older Stories